Aurinia Pharmaceuticals Inc AUPH
16.44
(0.16)
(0.96%)
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 6.9×
Follow AUPH
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
20.65% | 59.91% | 64.98% | 66.12% | |
| 14.46% | 44.11% | 48.54% | 48.52% | ||
ROIC |
71.84% | 30.35% | 34.24% | 40.76% | |
Return on Tangible Assets |
21.34% | 71.74% | 75.37% | 70.86% | |
Average Days of Receivables |
42.19 | 53.46 | 60.17 | 48.20 | |
Free Cash Flow per Share |
0.91 | 1.01 | 1.26 | 1.35 | |
Free Cash Flow |
119.87 | 135.41 | 166.64 | 175.07 | |
Capital Expenditures |
(0.24) | (0.25) | (0.27) | (0.18) | |
Piotroski F-Score |
8.00 | 7.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
15.53% | 13.15% | 16.78% | 15.90% | |
Accounts Receivable Turnover |
7.91 | 7.26 | 6.66 | 7.67 | |
Accounts Payable Turnover |
1.00 | 7.69 | 8.89 | 11.90 | |
Inventory Turnover |
0.70 | 0.77 | 0.66 | 0.66 | |
Average Days of Payables |
27.47 | 37.02 | 31.74 | 21.08 | |
Days of Inventory on Hand |
555.76 | 510.54 | 553.66 | 548.68 | |
Tax Rate |
(0.02) | 1.52 | 1.23 | 0.96 | |
Research and Development Expense of Revenue |
11.18% | 11.48% | 11.48% | 12.79% | |
Selling, General and Administrative Expense of Revenue |
41.22% | 35.96% | 34.69% | 32.41% | |
Share Based Compensation of Revenue |
6.36% | 5.19% | 5.77% | 4.69% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.54 | 0.47 | 0.56 | 0.56 | |
Depreciation/Fixed assets |
8.58 | 9.21 | 9.77 | 10.41 | |
Capex/Depreciation |
(0.01) | (0.01) | (0.01) | (0.01) | |
Revenue per Share |
2.02 | 2.11 | 2.25 | 2.39 | |
Operating CF per Share |
0.91 | 1.01 | 1.26 | 1.35 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
29.28% | 101.47% | 99.97% | 100.84% |
Columns are period end dates